Evio.vc

Evio.vc is an emerging European venture firm with a minimal disclosed footprint beyond its website, LinkedIn, and Crunchbase presence. Without published thesis, stage, or check data, the most honest read is that this is an early or single-fund manager working a generalist tech mandate with selective health and AI sleeves rather than a dedicated healthcare investor. Healthcare founders should not assume domain depth here; expect interest in horizontal AI, vertical SaaS, and consumer applications, with health considered when an obvious software-style business model and clear regulatory path are visible. AI focus is plausibly central given the firm’s positioning and naming, with a likely tilt toward applied AI rather than foundation models or wet-lab biotech. Anchor expectations on emerging-manager norms: pre-seed and seed checks of roughly EUR 100K to EUR 750K, co-investing or leading small rounds with notable European angels and seed funds. This is not a fit for therapeutics, devices, or any company that needs deep clinical, regulatory, or payor expertise from its capital partners. It is a possible fit for AI-native digital health, healthtech infrastructure, or provider-workflow teams that already have a domain-experienced lead and want a fast, founder-friendly European seed co-investor. Entry path is the website contact and the LinkedIn page; brief, specific notes that name a portfolio comparison and a clear ask outperform generic decks. Expect a quick yes or pass and limited post-investment platform support.